Pune, India-- (SBWIRE) -- 08/16/2016 -- Depression is a serious mood disorder, affecting the ability to think, feel, and handle situations like sleeping, eating, or working. It is a mood disorder that causes a persistent feeling of sadness and loss of interest. It builds up a very negative perspective in the way of thinking in every single thing and damages a person's ability to see brighter versions of any situation in life. It is of various types like major depressive disorder (MDD), perinatal depression, psychotic depression, seasonal depression and bipolar depression.

Complete report now available at http://www.marketreportsonline.com/496438.html.

To be diagnosed with depression, the symptoms must be present for at least two weeks. It may require long-term treatment for years. There is no single cause of depression; it is likely an outcome from combinations of genetic, biochemical, environmental and physiological factors. There are several ways of treating depression depending upon each individual's characteristics & symptoms. Most people feel better with medication, psychological counseling or both.

The global depressive disorder market is expected to grow and overcome falling revenues due to patent expiry with better innovative drugs and therapies. The US has highest depression disorder prevalence along with highest prevalence of bipolar depression & schizophrenia. With growing awareness and better access to medical facilities, the depressive disorder market is expected to grow worldwide, especially in Asia-Pacific region.

The key factors driving the growth of the depressive disorder market includes increased smoking prevalence, rising healthcare expenditure, growing female population, increasing spending on medicines and rising number of prescription drugs. However, there are certain factors hindering the growth of the market like patent expiry, severe side effects of drugs, and tough regulations. Major trends of the market include novel drug approvals, major drugs in pipeline, and growing public awareness.

Company Coverage of Global Depressive Disorder Market: Lundbeck, Eli Lilly and Company, AstraZeneca & Pfizer Inc.

Purchase a copy of this "Global Depressive Disorder Market" research report at http://www.marketreportsonline.com/contacts/purchase.php?name=496438.

The report offers an in-depth analysis of the "Global Depressive Disorder Market" segmented into global and regional markets. Competition is concentrated in the hands of few major pharmaceutical companies out of which Pfizer Inc., AstraZeneca, Eli Lilly and company, and Lundbeck have been covered in the report.

Key Topics Covered in Global Depressive Disorder Market:

1. Market Overview
2. Global Market
3. Regional Markets
4. Market Dynamics
5. Competitive Landscape
6. Company Profiles

List of Tables (http://www.marketreportsonline.com/496438-toc.html) Provided in Global Depressive Disorder Market:

Novel Drug Approvals for Depression Disorder (2015)
Major Rapid Acting Depression Drugs in Development (2015)
Severe Side-Effects of Depression Disorder Drugs
Global Anti-Depressants Market Comparison by Product Profile (2015)
Global Anti-Psychotics Market Comparison by Product Profile (2015)
New Products of Pfizer with FDA Approval (2015/2016)
Approvals and Upcoming Drugs (2015)
Lundbeck's New Drugs in Development (2015)

Browse All Latest Pharmaceuticals Market Research Reports at http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.

About MarketReportsOnline
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Contact Us:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
Tel: 888-391-5441
E-mail: sales@marketreportsonline.com